Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OMBITASVIR for Chronic hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 113 adverse event reports in the FDA FAERS database where OMBITASVIR was used for Chronic hepatitis c.

Most Reported Side Effects for OMBITASVIR

Side Effect Reports % Deaths Hosp.
Anaemia 39 14.6% 5 4
Fatigue 34 12.7% 5 3
Hyperbilirubinaemia 30 11.2% 2 5
Drug interaction 24 9.0% 1 11
Headache 21 7.9% 0 2
Hepatitis c 21 7.9% 0 0
Nausea 21 7.9% 2 6
Insomnia 19 7.1% 0 0
Hepatic failure 17 6.4% 6 2
Alanine aminotransferase increased 16 6.0% 2 4
Hepatocellular carcinoma 16 6.0% 4 2
Virologic failure 16 6.0% 1 0
Pruritus 14 5.2% 1 0
Foot fracture 13 4.9% 0 0
Osteoporosis 13 4.9% 0 0

Other Indications for OMBITASVIR

Hepatitis c (92) Hepatitis c virus test positive (30) Hepatic cirrhosis (12) Antiviral treatment (6)

Other Drugs Used for Chronic hepatitis c

RIBAVIRIN (15,707) PEGINTERFERON ALFA-2A (7,898) LEDIPASVIR\SOFOSBUVIR (6,621) SOFOSBUVIR\VELPATASVIR (6,405) SOFOSBUVIR (6,008) TELAPREVIR (3,103) GLECAPREVIR\PIBRENTASVIR (3,072) SIMEPREVIR (2,735) DACLATASVIR (2,063) PEGINTERFERON ALFA-2B (1,927)

Related Pages

OMBITASVIR Full Profile All Chronic hepatitis c Drugs OMBITASVIR Demographics OMBITASVIR Timeline